Shanghai Xiao Fang Pharmaceutical (603207.SH) awarded 1.28 million restricted shares to 178 incentive recipients.
Xiaofang Pharmaceuticals (603207.SH) announced that the company's board of directors believes that the company's 2025 restricted stock incentive...
Shanghai Xiao Fang Pharmaceutical (603207.SH) announced that the company's board of directors believes that the conditions for granting restricted stocks as prescribed in the company's 2025 Restricted Stock Incentive Plan have been met. The company has determined that the initial grant date for this incentive plan is February 13, 2025, and has agreed to grant 1.28 million restricted stocks to 178 incentive recipients at a price of 14.97 yuan per share.
Related Articles
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
